Article | February 1, 2018

Driving Change In Biomanufacturing

Source: Cytiva

By Jenny Dunker, Global Product Marketing Manager, BioProcess Hardware, GE Healthcare

Driving Change In Biomanufacturing

Two commonly asked questions about in-line buffer preparation

Whatever the objective, driving change is a challenge. Implementing a new technology into a bioprocess is a big change. The new technology must be fully understood, all regulatory requirements fulfilled, the quality of the product output secured, and a thorough risk mitigation conducted.

Biomanufacturing require many unique buffers and some might be complex to prepare, posing challenges to planning for manning, logistics, and scheduling. With in-line conditioning (IC), buffers are prepared just-in-time, simplifying logistics and securing critical quality attributes.

Changing from traditional buffer preparation to IC would mean implementing a new control strategy—driving a change. Here, are the answers to the two most common questions from our customers that can help you drive the change of implementing IC at your facility.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: